Skip to content
Tapping Psychedelics for their Anti-Inflammatory Powers episode artwork

Feb 4, 2021 31 min

Tapping Psychedelics for their Anti-Inflammatory Powers

from The Bio Report Hosted by Levine Media Group

There’s been a growing industry effort to explore the use of psychedelics for their medicinal benefits. While much of these efforts have looked to these drugs to treat a range of psychiatric conditions, Eleusis sees a broader potential for them. While the company is pursuing psychedelics as potential treatments for major depressive disorder, it also is developing psychedelic candidate in other indications because of their anti-inflammatory properties. We spoke to Shlomi Raz, CEO of Eleusis, about of the case for psychedelics as treatments for inflammatory conditions, how they work, and what challenges the development of these drugs pose.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Tapping Psychedelics for their Anti-Inflammatory Powers

0:00 31:44

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of The Bio Report?

This episode is 31 minutes long.

When was this The Bio Report episode published?

This episode was published on February 4, 2021.

Can I download this The Bio Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.